$15.52 -0.35 (%) Endo International plc - NASDAQ

Dec. 6, 2016 | 10:49 AM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Generic Drugs Probe Seen As Possible 'Severe' Sector Overhang

    TalkMarkets | Nov. 4, 2016 | 13:40PM EST
  2. The 5 Worst-Performing S&P 500 Stocks In 2016

    TalkMarkets | Oct. 10, 2016 | 13:10PM EST
  3. Wallace Weitz Comments on Endo International

    GuruFocus | Jan. 22, 2016 | 12:47PM EST
  4. Wallace Weitz Offers Rare Glimpse at Buys and Sells of 4th Quarter

    GuruFocus | Dec. 21, 2015 | 17:08PM EST
  5. Louis Moore Bacon Acquires More Than 1.5 Million Shares of JPMorgan Chase

    GuruFocus | Dec. 17, 2015 | 18:34PM EST
  6. Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Health Care Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  7. Health Care Investor Larry Robbins Sells Drug Manufacturers, Buys Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  8. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus | Nov. 17, 2015 | 13:13PM EST
  9. Benzinga's Top Downgrades

    Benzinga | Nov. 16, 2015 | 09:26AM EST
  10. 5 Worst Stock Ideas Of October

    Benzinga | Nov. 2, 2015 | 08:26AM EST
  11. FDA Approves BELBUCA Buccal Film for Chronic Pain Management

    Benzinga | Oct. 26, 2015 | 05:01AM EST
  12. Valeant Dives On Fraud Claim

    IBD | Oct. 21, 2015 | 18:14PM EST
  13. Valeant Dives As Short Seller Alleges Pharmacy Fraud

    IBD | Oct. 21, 2015 | 16:02PM EST
  14. Swedish Orphan Biovitrum AB Announces Approval of Xiapex by Swissmedic for Treatment of Peyronie's disease in Switzerland

    Benzinga | Oct. 16, 2015 | 03:24AM EST
  15. Benzinga's Top Initiations

    Benzinga | Oct. 9, 2015 | 08:34AM EST
  16. Worst Performing Industries For October 5, 2015

    Benzinga | Oct. 5, 2015 | 10:30AM EST
  17. Valeant Defended After Politics-Induced Sell-Off

    IBD | Sep. 29, 2015 | 11:45AM EST
  18. 10 Stocks Moving In Monday's After-Hours Session

    Benzinga | Sep. 28, 2015 | 15:47PM EST
  19. Benzinga's Top Downgrades

    Benzinga | Sep. 1, 2015 | 08:43AM EST
  20. Kyle Bass Focuses on Fuel, Pharmaceutical Stocks in Second Quarter

    GuruFocus | Aug. 24, 2015 | 18:15PM EST
  21. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 13:48PM EST
  22. Endo International Tops Q2 Estimates

    Benzinga | Aug. 10, 2015 | 07:02AM EST
  23. More Pharma Buyouts Ahead? 3 Top Stocks In Buy Range

    IBD | Aug. 3, 2015 | 17:21PM EST
  24. Mandel's Lone Pine Takes Stake in Growing Horizon Pharma

    GuruFocus | Jul. 28, 2015 | 01:14AM EST
  25. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD | Jul. 23, 2015 | 08:37AM EST
  26. Safer Pain Meds Developed

    IBD | Jul. 17, 2015 | 18:06PM EST
  27. Benzinga's Top Upgrades

    Benzinga | Jul. 17, 2015 | 08:20AM EST
  28. Painkiller Abuse Drives Drugmakers To Innovate

    IBD | Jul. 17, 2015 | 07:02AM EST
  29. Horizon Pharma Seen In Deal-Making Mode

    IBD | Jun. 26, 2015 | 11:27AM EST
  30. Dodge & Cox Buys 2 New Stocks

    GuruFocus | Jun. 10, 2015 | 23:20PM EST
  31. US Stock Futures Slip; All Eyes On Jobs Report

    Benzinga | Jun. 5, 2015 | 06:22AM EST
  32. Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'

    Benzinga | May. 22, 2015 | 09:34AM EST
  33. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 09:48AM EST
  34. 7 Biotech Stocks Moving Off The UBS Healthcare Conference

    Benzinga | May. 19, 2015 | 13:16PM EST
  35. Endo Buying Generics Maker

    IBD | May. 18, 2015 | 17:54PM EST
  36. Stocks Rise Despite Greek Woes; Skyworks, Altera Jump

    IBD | May. 18, 2015 | 15:24PM EST
  37. Stocks Find Their Footing; Skyworks Nears Breakout

    IBD | May. 18, 2015 | 10:54AM EST
  38. Endo Buying Par Pharma To Become Top Generics Player

    IBD | May. 18, 2015 | 09:38AM EST
  39. Endo Pharmaceuticals Posts A Solid Q1 Earnings Report

    GuruFocus | May. 12, 2015 | 12:57PM EST
  40. Endo raises full-year outlook

    IBD | May. 11, 2015 | 17:46PM EST
  41. Actavis Offers Post-Allergan Guidance; Ligand Jumps

    IBD | May. 11, 2015 | 17:36PM EST
  42. Dow Leads Market Gains; NYSE Winners Top Losers 4-1

    IBD | May. 8, 2015 | 15:57PM EST
  43. Is The Drug Industry's Wedding Dance Nearly Finished?

    IBD | May. 1, 2015 | 15:08PM EST
  44. DepoMed Set To Grow On 'Transformative' Nucynta Deal

    IBD | Apr. 23, 2015 | 15:16PM EST
  45. Autohome, Other Foreign Stock Leaders Seen Posting Big Q1 Growth

    IBD | Apr. 13, 2015 | 16:17PM EST
  46. Weekly Insider Sells Highlight: ANTM, ENDP, QVCA, TOL

    GuruFocus | Apr. 13, 2015 | 01:25AM EST
  47. Analyst: Boston Scientific's Acquisition Is 'Strategically Sound'

    Benzinga | Mar. 3, 2015 | 16:10PM EST
  48. Benzinga's M&A Chatter for Monday March 2, 2015

    Benzinga | Mar. 2, 2015 | 19:29PM EST
  49. Endo to sell device business

    IBD | Mar. 2, 2015 | 18:45PM EST
  50. 'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In Total Deals

    Benzinga | Mar. 2, 2015 | 13:19PM EST
Trading Center